Does Ozempic deserve a blanket 'don't take it' warning?

What did @thehonestattorney actually say?

A Florida injury attorney posted a TikTok telling viewers to "stop taking Ozempic" because "patients are filing lawsuits for paralysis of the stomach" and that the damage is "sometimes permanent." He linked semaglutide and tirzepatide ("Manjaro") to gastroparesis, described it as a condition where "your stomach literally stops working," and warned that plaintiffs claim they "were never warned" about the risk. He closed with an urgent call to send the video to anyone currently on the drug.

The hashtags included #druginjurylawyer and #schneiderinjuryfirm. This is not a neutral health educator. That context matters when you're parsing how he framed every sentence.

Does the science back this up?

Partially, but the framing is more alarming than the actual evidence justifies. There is a real signal here. The problem is how he characterized it.

A widely cited 2023 study by Sodhi et al. in JAMA found that GLP-1 receptor agonist users had a significantly higher risk of gastroparesis compared to users of bupropion-naltrexone. Specifically, the adjusted incidence rate for gastroparesis was roughly 9.09 per 1,000 person-years in GLP-1 users versus 1.53 for the comparator group. That is a real, statistically significant association.

However, the absolute numbers remain small, and this was an observational study, not a randomized trial. Causation has not been established. GLP-1 drugs slow gastric emptying by design. Whether that mechanism causes true, irreversible gastroparesis in a meaningful portion of patients, or whether pre-existing risk factors are doing the work, is still an open question. A 2023 analysis by Camilleri in Gut noted that most gastroparesis-like symptoms in GLP-1 users appear to resolve after stopping the drug, which directly contradicts the "permanent damage" framing.

What did they get wrong (or right)?

He got the existence of the risk basically right. He got the severity and permanence badly wrong, and that distinction is not a minor detail.

Calling this "paralysis of the stomach" that leads to "permanent damage" for a significant share of users is not what the current data shows. The word "paralysis" implies a dramatic, irreversible failure. What the studies show is delayed gastric emptying that, in a subset of patients, meets clinical criteria for gastroparesis. For most people who develop GI symptoms on semaglutide, those symptoms improve with dose reduction or discontinuation.

He also said patients "were never warned." That is the litigation framing, not the clinical framing. Gastroparesis and severe GI events are listed in semaglutide prescribing information, though critics argue the warnings were not prominent enough early on. That is a legitimate regulatory debate. Presenting it as a suppressed secret is a stretch.

To give credit where it is due: his advice to "not ignore any new symptoms and talk to your doctor" is sound. That part is accurate and responsible.

What should you actually know?

If you are taking semaglutide or tirzepatide, the gastroparesis association is real and worth knowing about. It is not a reason to panic or stop your medication without medical guidance, which is exactly the opposite of what this video recommends.

Blanket "don't take it" advice ignores that these drugs have demonstrated cardiovascular benefits in type 2 diabetes patients (the SELECT trial, Marso et al., 2016, NEJM), meaningful weight loss outcomes, and a risk-benefit profile that a physician, not a personal injury attorney, should be evaluating for each individual patient.

The FDA has been reviewing GLP-1-related GI adverse event reports and updated labeling. If you are experiencing persistent nausea, vomiting, or abdominal pain on a GLP-1 drug, you should contact your prescriber. Dose adjustments, slower titration, or switching agents are all options your doctor can discuss with you. Stopping abruptly without medical supervision can also carry risks, particularly for people managing type 2 diabetes.

The litigation wave is real. The lawsuits are real. But lawsuits are not the same as proven medical consensus, and an attorney with a firm hashtag in his bio has a financial interest in how alarming this story sounds.